Volume 88 Issue 47 | p. 17 | Concentrates
Issue Date: November 22, 2010

Lupus Drug Nears FDA Approval

Department: Business, Government & Policy
Keywords: lupus, Human Genome Sciences, Benlysta

An FDA advisory committee has recommended approval for Benlysta, a monoclonal antibody to treat lupus being developed by Human Genome Sciences and GlaxoSmithKline. If approved, Benlysta would be the first new drug in decades to treat lupus, a chronic disease that occurs when immune system antibodies attack healthy tissues. It would also be Human Genome’s first marketed product. Benlysta works by blocking B-lymphocyte stimulator, a protein that is overexpressed . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society